Søren Feddersen

Søren Feddersen serves as an Associate Professor in the Department of Clinical Research at the University of Southern Denmark's Faculty of Health Sciences, with dual appointments at Odense University Hospital (OUH) and the Research Unit of Clinical Biochemistry in Odense. His work bridges laboratory science and clinical applications through biomarker discovery across multiple disease domains.

His research centers on molecular mechanisms in cardiovascular pathology, cancer progression, and infectious disease diagnostics, with particular expertise in microRNA profiling, genetic variant analysis, and cytokine signature identification. Current projects investigate JAK2 mutations in aortic aneurysms, pharmacogenomics in breast cancer treatment, and novel biomarkers for prostate cancer and tuberculosis diagnosis.

Recent publications (2024-2025) demonstrate a strong translational focus through population-based cohort studies and diagnostic validation trials, frequently involving multi-center collaborations across cardiology, oncology, and immunology. His work consistently emphasizes clinically applicable biomarker discovery using plasma, blood, and tissue samples.

Dr. Feddersen has supervised at least one Ph.D. thesis as indicated by institutional records. His collaborative network spans Karolinska Institutet (KI), Odense University Hospital, and international research teams, reflecting engagement in large-scale funded projects though specific grant details aren't publicly itemized.

He operates within the Research Unit of Clinical Biochemistry at OUH, contributing to SDU's clinical research infrastructure through interdisciplinary teams focused on molecular diagnostics and precision medicine applications.